Summary
OneProjects is a new medical device company based in Dublin and Munich developing the new wave of disruptive cardiac imaging
innovations that will provide a sea change in the treatment of atrial fibrillation (AFib) through ablation. With the clinical need at the
core of our mission and world-class expertise in medical imaging and product commercialisation, OneProjects is developing
VERAFEYE, a novel smart catheter system that provides real-time 4D ablation/tissue analysis and navigation enabled through
advanced imaging and analytics.
VERAFEYE is a breakthrough connected technology which can generate unprecedented 4D data during the ablation procedure, thus
providing the physician with real-time analysis of the surgery. VERAFEYE will for the first time allow clinicians to correct and enhance
the treatment in the 1st procedure, ensuring the patient is AFib free, and hence remove the need for multiple surgeries. VERAFEYE
will shift treatment to the era of evidence- and data-based success rather than purely relying on the experience of the
electrophysiologist as is currently the case.
innovations that will provide a sea change in the treatment of atrial fibrillation (AFib) through ablation. With the clinical need at the
core of our mission and world-class expertise in medical imaging and product commercialisation, OneProjects is developing
VERAFEYE, a novel smart catheter system that provides real-time 4D ablation/tissue analysis and navigation enabled through
advanced imaging and analytics.
VERAFEYE is a breakthrough connected technology which can generate unprecedented 4D data during the ablation procedure, thus
providing the physician with real-time analysis of the surgery. VERAFEYE will for the first time allow clinicians to correct and enhance
the treatment in the 1st procedure, ensuring the patient is AFib free, and hence remove the need for multiple surgeries. VERAFEYE
will shift treatment to the era of evidence- and data-based success rather than purely relying on the experience of the
electrophysiologist as is currently the case.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/960768 |
| Start date: | 01-10-2020 |
| End date: | 30-06-2023 |
| Total budget - Public funding: | 4 349 717,00 Euro - 2 500 000,00 Euro |
Cordis data
Original description
OneProjects is a new medical device company based in Dublin and Munich developing the new wave of disruptive cardiac imaginginnovations that will provide a sea change in the treatment of atrial fibrillation (AFib) through ablation. With the clinical need at the
core of our mission and world-class expertise in medical imaging and product commercialisation, OneProjects is developing
VERAFEYE, a novel smart catheter system that provides real-time 4D ablation/tissue analysis and navigation enabled through
advanced imaging and analytics.
VERAFEYE is a breakthrough connected technology which can generate unprecedented 4D data during the ablation procedure, thus
providing the physician with real-time analysis of the surgery. VERAFEYE will for the first time allow clinicians to correct and enhance
the treatment in the 1st procedure, ensuring the patient is AFib free, and hence remove the need for multiple surgeries. VERAFEYE
will shift treatment to the era of evidence- and data-based success rather than purely relying on the experience of the
electrophysiologist as is currently the case.
Status
CLOSEDCall topic
EIC-SMEInst-2018-2020Update Date
27-10-2022
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
